BARCELONA—In patients with previously irradiated locally recurrent prostate cancer, salvage high-dose-rate brachytherapy (HDRB) was an effective and safe treatment option. The 3rd ESTRO Forum (April 24-28, 2015) heard data from a retrospective analysis with 60 patients that found HDRB had acceptable late genitourinary toxicity after external beam radiotherapy. Study author Manuel Galdeano Rubio MD from Institut Català d’Oncologia discussed the findings with Oncology Times reporter Sarah Maxwell.
Salvage Prostate High-Dose-Rate Brachytherapy: Effective and Safe after External Beam Radiotherapy
Further reading
Babies Use Object Permanence To Get What They Want 2022: A report from the journal: Pediatric Physical Therapy Regina Harbourne PhD, PT, PCS, FAPTA...
Mandeep Mehra talks about his report in the New England Journal of Medicine on the inflammatory effects of COVID-19 infection and the implications...
January 2020 Pediatric Physical Therapy journal highlights the importance of non-billable tasks that are essential to achieving good outcomes. The...
SOURCE: Pediatric Physical Therapy journal ARTICLE “Trends in Attitudes and Practice Patterns of Physical Therapists in Addressing Childhood...
Uptake of the Congenital Muscular Torticollis Guidelines Survey findings about the effectiveness of a recently-introduced clinical practice guideline...
BARCELONA—A new pencil beam scanning proton delivery technique—rescanning—could help limit the dose of radiation to surrounding tissues and organs by...